• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Growth differentiation factor 15: a promising biomarker in oral cancer.生长分化因子15:口腔癌中一种有前景的生物标志物。
J Korean Assoc Oral Maxillofac Surg. 2025 Apr 30;51(2):123-125. doi: 10.5125/jkaoms.2025.51.2.123.
2
GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma.生长分化因子 15 作为口腔鳞状细胞癌的抗凋亡、诊断和预后标志物。
Oral Oncol. 2012 Jul;48(7):608-14. doi: 10.1016/j.oraloncology.2012.01.020. Epub 2012 Feb 16.
3
Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by Analysis of Differential Gene Expression.揭示血清 miR-483-5p 的潜力:通过差异基因表达分析,作为 OLp 和 OSCC 患者的有前途的诊断和预后生物标志物。
Curr Pharm Des. 2024;30(4):310-322. doi: 10.2174/0113816128276149240108163407.
4
Expression and clinical role of growth differentiation factor-15 in ovarian carcinoma effusions.生长分化因子 15 在卵巢癌性胸水中的表达及其临床作用。
Int J Gynecol Cancer. 2010 Dec;20(9):1448-55. doi: 10.1111/IGC.0b013e3181f7d6be.
5
The impact of the expression level of growth differentiation factor 15 in tumor tissue on the response to immunotherapy in non-small cell lung cancer.肿瘤组织中生长分化因子 15 的表达水平对非小细胞肺癌免疫治疗反应的影响。
BMC Cancer. 2024 Aug 5;24(1):954. doi: 10.1186/s12885-024-12727-3.
6
Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.血清生长分化因子15水平升高与口腔白斑和口腔鳞状细胞癌相关。
J Oral Pathol Med. 2014 Jan;43(1):28-34. doi: 10.1111/jop.12091. Epub 2013 May 26.
7
Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.PLOD2作为口腔鳞状细胞癌不良预后生物标志物的鉴定与验证
Biomolecules. 2021 Dec 7;11(12):1842. doi: 10.3390/biom11121842.
8
Growth differentiation factor 15 as a radiation-induced marker in oral carcinoma increasing radiation resistance.生长分化因子15作为口腔癌中辐射诱导的标志物可增加辐射抗性。
J Oral Pathol Med. 2016 Jan;45(1):63-9. doi: 10.1111/jop.12323. Epub 2015 Apr 16.
9
Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.AQUAnalysis 检测的 Bax 表达是口腔鳞状细胞癌的独立预后标志物。
BMC Cancer. 2012 Aug 1;12:332. doi: 10.1186/1471-2407-12-332.
10
Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.血小板衍生生长因子及其受体的过表达与口腔鳞状细胞癌的口腔肿瘤发生和不良预后相关。
Int J Mol Sci. 2020 Mar 29;21(7):2360. doi: 10.3390/ijms21072360.

本文引用的文献

1
Ponsegromab for the Treatment of Cancer Cachexia.泊塞格单抗用于治疗癌症恶病质。
N Engl J Med. 2024 Dec 19;391(24):2291-2303. doi: 10.1056/NEJMoa2409515. Epub 2024 Sep 14.
2
The impact of the expression level of growth differentiation factor 15 in tumor tissue on the response to immunotherapy in non-small cell lung cancer.肿瘤组织中生长分化因子 15 的表达水平对非小细胞肺癌免疫治疗反应的影响。
BMC Cancer. 2024 Aug 5;24(1):954. doi: 10.1186/s12885-024-12727-3.
3
Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC): A systematic review and network meta-analysis.用于早期检测口腔鳞状细胞癌(OSCC)和头颈部鳞状细胞癌(HNSCC)的唾液生物标志物:一项系统评价和网状荟萃分析。
Jpn Dent Sci Rev. 2024 Dec;60:32-39. doi: 10.1016/j.jdsr.2023.10.003. Epub 2023 Dec 21.
4
A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia.一项评估 Ponsegromab 在癌症恶病质患者中的安全性、耐受性、药代动力学和药效学的 Ib 期首次人体研究。
Clin Cancer Res. 2024 Feb 1;30(3):489-497. doi: 10.1158/1078-0432.CCR-23-1631.
5
Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics (Review).口腔鳞状细胞癌中新兴的组织学和血清学生物标志物:在诊断、预后评估和个体化治疗中的应用(综述)。
Oncol Rep. 2023 Dec;50(6). doi: 10.3892/or.2023.8650. Epub 2023 Oct 20.
6
Macrophage inhibitory cytokine-1 in cancer: Beyond the cellular phenotype.巨噬细胞抑制细胞因子-1 在癌症中的作用:超越细胞表型。
Cancer Lett. 2022 Jun 28;536:215664. doi: 10.1016/j.canlet.2022.215664. Epub 2022 Mar 26.
7
Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia.生长分化因子 15(GDF15)在肥胖症、癌症和恶病质中的病理生理学作用。
Cytokine Growth Factor Rev. 2022 Apr;64:71-83. doi: 10.1016/j.cytogfr.2021.11.002. Epub 2021 Nov 17.
8
Mechanism of sensitivity to cisplatin, docetaxel, and 5-fluorouracil chemoagents and potential erbB2 alternatives in oral cancer with growth differentiation factor 15 overexpression.生长分化因子 15 过表达口腔癌对顺铂、多西他赛和 5-氟尿嘧啶化疗药物的敏感性机制及潜在 erbB2 替代物。
Cancer Sci. 2022 Feb;113(2):478-488. doi: 10.1111/cas.15218. Epub 2021 Dec 20.
9
Identification and validation of potential novel biomarkers for oral squamous cell carcinoma.口腔鳞状细胞癌潜在新型生物标志物的鉴定和验证。
Bioengineered. 2021 Dec;12(1):8845-8862. doi: 10.1080/21655979.2021.1987089.
10
The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?健康与代谢性疾病中的GDF15-GFRAL通路:益友还是敌人?
Annu Rev Physiol. 2021 Feb 10;83:127-151. doi: 10.1146/annurev-physiol-022020-045449. Epub 2020 Nov 23.

生长分化因子15:口腔癌中一种有前景的生物标志物。

Growth differentiation factor 15: a promising biomarker in oral cancer.

作者信息

Oh Hyun Jun, Lee Jong-Ho, Kim Soung Min

机构信息

Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Korea.

出版信息

J Korean Assoc Oral Maxillofac Surg. 2025 Apr 30;51(2):123-125. doi: 10.5125/jkaoms.2025.51.2.123.

DOI:10.5125/jkaoms.2025.51.2.123
PMID:40296737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12041432/
Abstract

Growth differentiation factor 15 (GDF-15), a cytokine within the transforming growth factor-β superfamily, is involved in various malignancies, with implications in oral squamous cell carcinoma (OSCC). Elevated GDF-15 levels are correlated with unfavorable prognosis, tumor progression, and chemotherapy resistance, and the protein has been identified as a potential diagnostic and prognostic biomarker for OSCC. Personalized treatment strategies based on GDF-15 expression could improve treatment outcomes.

摘要

生长分化因子15(GDF-15)是转化生长因子-β超家族中的一种细胞因子,参与多种恶性肿瘤,与口腔鳞状细胞癌(OSCC)有关。GDF-15水平升高与不良预后、肿瘤进展和化疗耐药相关,该蛋白已被确定为OSCC的一种潜在诊断和预后生物标志物。基于GDF-15表达的个性化治疗策略可能会改善治疗效果。